Alteplase is currently the standard thrombolytic agent used for treating acute ischemic stroke when administered within 4.5 hours of symptom onset. However, with the rising demand for thrombolytic agents, there is an increasing need to investigate alternative options. Reteplase, a recombinant plasminogen activator delivered in two fixed-dose boluse
1691 Reached10 Comments1 Likes
Carpal Tunnel Syndrome due to Tophaceous Gout in Flexor Tendon
282 Reached5 Comments7 Likes
Complicated case of Osteoarthritis
1849 Reached2 Comments3 Likes
Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments
Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes